SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-298184
Filing Date
2023-12-19
Accepted
2023-12-19 08:32:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d784508ddefa14a.htm DEFA14A 11472
2 GRAPHIC g784508g03m68.jpg GRAPHIC 322039
3 GRAPHIC g784508g88u56.jpg GRAPHIC 201445
  Complete submission text file 0001193125-23-298184.txt   733770
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36544 | Film No.: 231495686
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)